已收盤 05-22 16:00:00 美东时间
-0.070
-0.33%
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx药业"超配"评级,目标价从84美元升至96美元;Ascendiant Capital:维持Liqtech国际"买入"评级,目标价从4.3美元升至4.4美元
05-22 10:18
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $17 to $22.
05-22 03:54
A Delaware federal judge dismissed the securities lawsuit against The Chemours ...
05-22 03:14
豪赌光通信未来?POET惨跌8%,却迎多头“海啸级”扫货;110美元关口迎来末日对决!NOW期权放量看涨占比超8成;英伟达绩后或迎6.5%波动>>
05-20 19:20
Figma涨13.39%;POET Technologies涨12.06%;Redwire Corp涨6.86%
05-15 09:01
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Buy and raises the price target from $29 to $30.
05-09 06:10
Chemours shares slipped over 13% during early trading hours on Wednesday after the company reported mixed first-quarter results. The company reported Q1 non-GAAP EPS of $0.05, beating market estimates...
05-06 23:15
Memory is yesterday's trade. Liquid cooling is the next AI backlog story — Carrier orders up 500%, Trane lead times doubled. Here are 10 stocks.
05-06 22:31